The unexpected association between low leptin levels and worse outcomes in patients with pulmonary embolism may be explained by the concept of the “obesity paradox”—a phenomenon suggesting that leptin’s role extends beyond merely reflecting body mass. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.